Commandité
DMCA
Novo Nordisk CEO to step down amid market challenges and stock plunge
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
© 2025 Dununu.com : Circle of Life - Santan Social Network
French
French
English
नेपाली
हिन्दी
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Arabic
অসমীয়া
বাংলা